Impact of immunohistochemical markers, CK5/6 and E-cadherin on diagnostic agreement in non-invasive proliferative breast lesions.

@article{Macgrogan2008ImpactOI,
  title={Impact of immunohistochemical markers, CK5/6 and E-cadherin on diagnostic agreement in non-invasive proliferative breast lesions.},
  author={Ga{\"e}tan Macgrogan and Laurent Arnould and Isabelle de Mascarel and Anne Vincent-Salomon and Fr{\'e}d{\'e}rique Penault-Llorca and Magali Lacroix-Triki and Fr{\'e}d{\'e}ric Bibeau and Marie Christine Baranzelli and Vadim Fridman and M Antoine and V{\'e}ronique Becette and V{\'e}ronique Brouste and Jocelyne D. Jacquemier and Simone Mathoulin-P{\'e}lissier},
  journal={Histopathology},
  year={2008},
  volume={52 6},
  pages={689-97}
}
AIMS To assess the impact of cytokeratin (CK) 5/6 and E-cadherin immunohistochemistry on diagnostic agreement of non-invasive proliferative breast lesions. METHODS AND RESULTS Twenty pathologists classified 105 cases of non-invasive proliferative breast lesions into 10 diagnostic categories. One haematoxylin and eosin (H&E) slide of each case was analysed on a first round and one H&E slide with corresponding CK5/6 and E-cadherin immunohistochemistry was analysed on a second round… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

[Benign proliferative breast disease with and without atypia].

Journal de gynecologie, obstetrique et biologie de la reproduction • 2015
View 10 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…